Tele: 561.316.3330
Breaking Medical Device News

Tuesday, October 19, 2021


HomeEXECUTIVESSid Bala Named President of HealthChampion

Sid Bala Named President of HealthChampion


Global $45 Billion Endoscopy Market Insights & Forecasts to 2025

The global endoscopy market is predicted to reach US$45.28 billion in 2025, growing, at a CAGR of 7.50%, for the duration spanning 2021-2025.

Global Remote Monitoring Devices Market Research Report (2021 to 2026)

Global Remote Monitoring Devices Market size was estimated at USD 1,035.35 million in 2020, is expected to reach USD 1,170.22 million in 2021.

Research Efforts Fuel the Future of Global Obstructive Lung Disease Management Markets –

The "Global Obstructive Lung Disease Management Research Report" report has been added.

Global Electrophysiology Market (2021 to 2026) – Growth, Trends , COVID-19 Impact and Forecasts –

The Electrophysiology Market is expected to register a CAGR of 8.5% during the forecast period.

Sid Bala has been named president of HealthChampion, a leading digital health analytics company.

Sid Bala has served as a board member since June 2020. He started as president of HealthChampion in August 2021.

“I am inspired every day to be part of a company that is positively impacting so many lives,” said Sid Bala. “HealthChampion is empowering people to take charge of their health as well as helping providers to care for their patients.”

HealthChampion engages patients and drives improved outcomes through its first-of-its-kind consumer-centric app. Since its founding in 2018, HealthChampion’s platform has connected tens of thousands of consumers to their own data, thus giving them information they need to take control of their healthcare. This is accomplished via personalized “pathways” to securely share information with family, payors, providers and employers. The service focusses on the entire continuum of care, including in-home, ambulatory, acute, post-acute, and at-home services.

“Sid’s decades of experience taking alligatortek from startup to top-performing company, combined with his proven leadership abilities, make him the perfect fit as we penetrate further into the marketplace,” says HealthChampion Chief Executive Officer Terrence M. Ryan. “He has a strong technology background, the passion and expertise to move us into new verticals, as well .”

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020. Bala led alligatortek for 27 years after he founded the business. In that time, he significantly grew the company, earning a Microsoft Partner of the Year award as well as repeat Chicago Innovation Awards.

As president of HealthChampion, Bala is focused on leading the company’s expansion into new markets. He is also charged with helping HealthChampion to further integrate sales, marketing, customer success, product and engineering expertise while leading the day-to-day operations of the company.

Bala earned his bachelor’s degree from the University of Chicago, and master’s degrees from Stony Brook University and Massachusetts Institute of Technology. He sits on the boards of directors and committees for a variety of organizations, including The Economic Club of Chicago, Silver Cross Hospital, Chicago Innovation and The Chicago Club.

Naming Bala as president of HealthChampion is the next step in the evolution of the company. HealthChampion has experienced significant growth with its most recent release of its secure COVID-19 vaccination card upload feature in its mobile app.; the launch of its revolutionary Chronic Care solution, a robust platform for healthcare providers and their recurring illness patients; and building out its leadership team with additional key hires.



Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®

The publication documents two critically ill COVID-19 patients receiving a combined total of nine, six-hour Hemopurifier® treatment sessions.

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression

For people with lymphedema, movement is important from both a clinical perspective and a quality-of-life perspective. These data illustrate the Dayspring treatment’s ability to provide that essential movement while still delivering the clinical outcomes we need from compression therapy.

18-Month Below-the-Knee Data with MedAlliance’s SELUTION SLR™ Presented as Late Breaking Trial at VIVA

“We have observed minimal slow-flow phenomena, seen with other paclitaxel drug-eluting balloons.  We have observed several cases of fast wound healing with SELUTION SLR. It is easy to track and deliver. We are looking forward to gaining further clinical experience with this device,” commented Prof. Chong.

Our Sister Publication: Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy